When a patient presents with a rapid heart rate, the margin for error is slim. Every decision you make(from the initial assessment to the choice between medication and electricity) can dramatically alter the patient’s trajectory. The American Heart Association’s (AHA) Adult Tachycardia With a Pulse Algorithm is your essential roadmap for navigating these high-pressure situations.
This guide provides a detailed walkthrough of the algorithm, reflecting the latest 2025 AHA updates. We’ll break down each step, from the initial stability assessment to the nuanced use of antiarrhythmics and electrical therapy, ensuring you have the knowledge to respond with speed, precision, and confidence.
Note: This ACLS tachycardia algorithm guideline is valid for 2025–2030.
The ACLS tachycardia algorithm is a systematic, evidence-based protocol published and regularly updated by the American Heart Association that guides medical teams through the rapid assessment and treatment of patients with excessively fast heart rates.
Although tachycardia is formally defined as a heart rate exceeding 100 beats per minute, the algorithm is designed for clinical application when rates reach ≥150/min, where the risk of hemodynamic instability rises substantially. This distinction is critical as many patients may have heart rates between 100-150 bpm due to appropriate physiological responses (e.g., fever, pain, anxiety, dehydration) rather than a pathological tachyarrhythmia requiring intervention. The algorithm is designed to be activated when the rate is sufficiently high to potentially cause hemodynamic instability, typically at or above the 150 bpm threshold.
The entire protocol revolves around one critical decision point: whether the patient is hemodynamically stable or unstable, and that distinction drives every treatment decision that follows.
Within the ACLS context, the focus is on tachyarrhythmias, pathological fast rhythms that can become life-threatening. This algorithm is specifically for patients who are tachycardic and have a pulse. Its purpose is to provide a systematic approach to differentiate between stable and unstable patients and guide you to the most appropriate and effective intervention.
Step 1: Assessment of Tachyarrhythmia
The first step is to identify whether the adult patient has a clinically significant tachyarrhythmia, typically indicated by a heart rate ≥150 beats per minute. This recognition helps determine whether the rhythm may be contributing to hemodynamic compromise and guides the urgency of further evaluation and treatment.
Step 2: Initial Assessment and Support
Initial management focuses on stabilizing airway, breathing, and circulation. Oxygen should be administered if the patient is hypoxemic, and continuous cardiac monitoring is essential to identify the rhythm and assess hemodynamic status. IV access should be established, and a 12-lead ECG should be obtained as soon as possible to support diagnosis and treatment planning.
Step 3: Evaluation for Instability
The patient should be assessed for signs of instability caused by the tachyarrhythmia, including hypotension, altered mental status, shock, ischemic chest discomfort, or acute heart failure. If any of these features are present, the rhythm is considered unstable and immediate intervention is required. If YES → Step 6, synchronized cardioversion should be performed without delay. If NO → Step 4, further rhythm evaluation is appropriate.
Step 4: QRS Duration Assessment
At this stage, the QRS duration is evaluated to determine whether the tachycardia is wide or narrow. A QRS duration ≥0.12 seconds indicates a wide-complex tachycardia requiring a different treatment approach. If YES → Step 8, the wide-complex pathway is followed. If NO → Step 5, management proceeds as a narrow-complex tachycardia.
Step 5: Management of Stable Narrow-Complex Tachycardia
Stable narrow-complex tachycardia is managed initially with vagal maneuvers if the rhythm is regular. If needed, adenosine may be administered to attempt rhythm conversion. Beta-blockers or calcium channel blockers can be used for rate control, and expert consultation should be considered if the rhythm persists or diagnosis is uncertain.
Step 6: Synchronized Cardioversion for Unstable Patients
Unstable tachyarrhythmias require immediate synchronized cardioversion to restore hemodynamic stability. Sedation should be provided whenever feasible without delaying the procedure. In selected cases of regular narrow-complex tachycardia, adenosine may be considered, but cardioversion remains the priority intervention.
Step 7: Management of Refractory Tachycardia
If tachycardia persists despite initial therapy, further evaluation for underlying causes is necessary. Treatment may involve escalating energy levels for repeat cardioversion or adding antiarrhythmic medications. Expert consultation is recommended to guide ongoing management and address complex or refractory cases.
Step 8: Management of Stable Wide-Complex Tachycardia
Stable wide-complex tachycardia may be treated with antiarrhythmic infusion therapy and close monitoring. Adenosine should only be considered if the rhythm is regular and monomorphic. Because wide-complex tachycardia may represent ventricular arrhythmia, expert consultation is strongly recommended to guide safe and effective treatment.
Synchronized Cardioversion:
Refer to your specific device’s recommended energy level or to relevant 2025 Guidelines sections to maximize first shock success. If not known, use the maximum energy setting.
Adenosine IV dose:
First dose: 6 milligrams rapid IV push; follow with NS flush. Second dose: 12 milligrams if required.
Antiarrhythmic Infusions for Stable Wide-QRS Tachycardia
Procainamide IV dose:
20 to 50 milligram per minute until arrhythmia suppressed, hypotension ensues, QRS duration increases greater than 50%, or maximum dose 17 milligrams/kilogram given. Maintenance infusion: 1 to 4 milligrams per minute. Avoid if prolonged QT or CHF.
Amiodarone IV dose:
First dose: 150 milligrams over 10 minutes. Repeat as needed if VT recurs. Follow by maintenance infusion of 1 milligrams per minute for first 6 hours.
Managing tachycardia with a pulse requires balancing speed with accuracy. Here are key takeaways for providers:
The entire algorithm hinges on the initial stability assessment. If a patient is hypotensive, has chest pain, or is unconscious, do not wait for a 12-lead ECG. Move directly to cardioversion.
Adenosine is a diagnostic and therapeutic tool, but is only for regular narrow or wide (monomorphic) rhythms. Administering it for an irregular wide rhythm (like Torsades or Afib with aberrancy) can be dangerous.
For conscious patients undergoing synchronized cardioversion, sedation (e.g., with midazolam, etomidate, or ketamine) is crucial for comfort and anxiety reduction. Ensure you have the skills and equipment to manage the airway if sedation causes respiratory depression.
When dealing with stable wide-complex tachycardia, the decision to use Adenosine hinges on the rhythm being “regular and monomorphic.” If it is polymorphic (varying shape), treat it as unstable or ischemic, and do not use AV nodal blockers.
Tachycardia management can become complex quickly. In stable patients with refractory rhythms or diagnostic uncertainty, early consultation with a cardiologist or electrophysiologist is always recommended.
Management of tachyarrhythmias with a pulse can be compromised by avoidable errors that delay effective treatment and worsen outcomes.
1. Delayed Synchronized Cardioversion
A major error is delaying synchronized cardioversion in unstable patients (hypotension, chest pain, altered mental status, shock). Electrical cardioversion should not be delayed for medications in unstable tachyarrhythmias.
Not activating sync mode before shock delivery can result in an unsynchronized shock, potentially triggering ventricular fibrillation. Always confirm synchronization before cardioversion.
Wide-complex tachycardia is often incorrectly identified. In unstable cases, it should be treated as ventricular tachycardia until proven otherwise to avoid treatment delays.
Using medications instead of immediate cardioversion in unstable patients is a critical error. Drugs may be adjuncts but should not replace urgent electrical therapy.
Failure to maintain airway, oxygenation, IV access, monitoring, and capnography can compromise stabilization and overall resuscitation effectiveness.
Ineffective communication, unclear roles, and lack of coordination can delay shock delivery and reduce treatment efficiency during emergencies.
Timely synchronized cardioversion, correct rhythm interpretation, and strong basic life support measures are essential to avoid preventable errors in tachyarrhythmia management.
In summary, the Adult Tachyarrhythmia With a Pulse Algorithm gives healthcare providers a clear and organized path to follow when facing a fast heart rhythm. It helps them quickly decide if the patient is stable or unstable and then choose the right treatment without delay. By moving step by step, it supports safe use of medicines, electrical therapy, and expert help when needed. This approach reduces confusion during emergencies and improves patient outcomes. With steady practice and good understanding, clinicians can respond faster, act with confidence, and provide better care when every second truly matters.
Get ACLS certified with Bayside CPR and earn more than a certification, get the confidence to save a life.
A tachyarrhythmia is a fast heart rhythm that often means the heart is beating 150 beats per minute or faster. It becomes important when it may affect blood flow and cause the patient to feel unwell or unstable.
The first step is to check airway, breathing, and circulation and give oxygen if needed. The team also connects heart monitors, starts IV access, and gets an ECG to understand the rhythm.
A patient is unstable if they have low blood pressure, confusion, chest pain, shock, or signs of heart failure. If these signs are present, immediate synchronized cardioversion is needed to quickly restore a safer rhythm.
QRS duration helps decide if the rhythm is narrow or wide, which changes the treatment plan. Narrow rhythms often use vagal maneuvers or adenosine while wide rhythms may need antiarrhythmic medicines and expert help.
If the rhythm continues, the team looks for underlying causes and may repeat cardioversion or adjust medications. Expert support is often needed to guide further treatment and keep the patient safe.
